RYAN SPECIALTY HOLDINGS, INC.
▲ 0 upgrades / ▼ 0 downgrades / 3 reiterations from 3 firms
Oct 29, 2026 (3 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Oct 7, 2026 | Mizuho | maintain | Neutral → Neutral | — | 52% |
| Oct 6, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Sep 16, 2026 | Mizuho | maintain | Neutral → Neutral | — | 52% |
| Aug 19, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Aug 3, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Aug 3, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 3, 2026 | JP Morgan | maintain | Underweight → Underweight | — | 55% |
| Aug 3, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Aug 3, 2026 | Cantor Fitzgerald | maintain | Neutral → Neutral | — | 50% |
| Jul 31, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 31, 2026 | Mizuho | maintain | Neutral → Neutral | — | 52% |
| Jul 31, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Jul 31, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Jul 31, 2026 | Keefe, Bruyette & Woods | maintain | Outperform → Outperform | — | 58% |
| Jul 31, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 15, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Jul 13, 2026 | JP Morgan | maintain | Underweight → Underweight | — | 55% |
| Jul 9, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 9, 2026 | Cantor Fitzgerald | maintain | Neutral → Neutral | — | 50% |
| Jul 9, 2026 | Mizuho | maintain | Neutral → Neutral | — | 52% |
| Jul 8, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Jul 8, 2026 | Keefe, Bruyette & Woods | maintain | Outperform → Outperform | — | 58% |
| Jul 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 6, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jul 1, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Jun 9, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Jun 8, 2026 | Goldman Sachs | downgrade | Buy → Neutral | — | 54% |
| May 21, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| May 4, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 4, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 1, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| May 1, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 1, 2026 | Keefe, Bruyette & Woods | maintain | Outperform → Outperform | — | 58% |
| May 1, 2026 | Wells Fargo | downgrade | Overweight → Equal-Weight | — | 54% |
| Apr 14, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Apr 13, 2026 | Mizuho | maintain | Neutral → Neutral | — | 52% |
| Apr 9, 2026 | JP Morgan | maintain | Underweight → Underweight | — | 55% |
| Apr 9, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Apr 9, 2026 | Cantor Fitzgerald | maintain | Neutral → Neutral | — | 50% |
| Apr 8, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Apr 8, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 8, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Apr 7, 2026 | Keefe, Bruyette & Woods | maintain | Outperform → Outperform | — | 58% |
| Apr 6, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Mar 23, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 11, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Feb 27, 2026 | Mizuho | maintain | Neutral → Neutral | $44 | 52% |
| Feb 25, 2026 | BMO Capital | downgrade | Outperform → Market Perform | $43 | 53% |
| Feb 23, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $55 | 54% |
No cross-platform signals in the last 90 days